Left Bundle Branch Block-associated Cardiomyopathy: A New Approach.
Shunmuga Sundaram Ponnusamy1, Pugazhendhi Vijayaraman2, Kenneth A Ellenbogen3
1Department of Cardiology, Velammal Medical College Madurai, India.
Arrhythmia & Electrophysiology Review
|October 25, 2024
Summary
Left bundle branch block (LBBB) often indicates heart disease. For LBBB-associated cardiomyopathy, conduction system pacing, like left bundle branch pacing, shows promise for reversing heart remodeling and improving outcomes.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure
Background:
- Left bundle branch block (LBBB) is linked to structural heart disease, increased morbidity, and mortality.
- Current guidelines suggest cardiac resynchronisation therapy (CRT) for cardiomyopathy with LBBB after 3 months of medical therapy.
- Medical therapy alone may be less effective, with most patients eventually requiring CRT.
Purpose of the Study:
- To review the mechanisms, evidence, and role of conduction system pacing in LBBB-associated cardiomyopathy.
- To highlight LBBB-associated cardiomyopathy as a potentially reversible condition.
- To discuss left bundle branch pacing as a CRT strategy.
Main Methods:
- Review of published literature on LBBB-associated cardiomyopathy and conduction system pacing.
- Analysis of clinical trial data regarding CRT efficacy in LBBB patients.
- Examination of reverse remodeling outcomes following left bundle branch pacing.
Main Results:
- CRT has demonstrated favorable clinical outcomes in patients with LBBB.
- Left bundle branch pacing can lead to significant reverse remodeling in LBBB-associated cardiomyopathy.
- Conduction system pacing offers a potential alternative CRT approach.
Conclusions:
- LBBB-associated cardiomyopathy may be reversible with appropriate pacing.
- Left bundle branch pacing is an effective strategy for CRT in selected patients.
- Conduction system pacing represents a valuable tool in managing heart failure with LBBB.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
1
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
1
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
1
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
1
01:25Cardiomyopathy I: Introduction and Classification
1
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
1
01:26Coronary Artery Disease IV: Medical Management
3
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
3